in eight subjects with parkinson 's disease under an optimal daily dose of l-dopa , acute administration of mif-i ( 200 mg i.v . ) did not ameliorate either the total disability score or the intellectual test pm 38 when evaluated in comparison with the effect induced by acute administration of a placebo .
C0030567
parkinson 's disease
C0023570
l-dopa